Severe Hyperammonemia In Late-onset Ornithine Transcarbamylase Deficiency Triggered By Steroid Administration

Publication date

2018-11-16T09:49:15Z

2018-11-16T09:49:15Z

2015

2018-07-24T12:35:22Z

Abstract

Ornithine transcarbamylase deficiency (OTCD) is a rare X-linked disorder of urea synthesis leading to hyperammonemia. Several late-onset cases have been reported. Undiagnosed and untreated patients are at the risk of death or suffering from irreversible sequelae. We describe a 56-year-old patient who presented with acute encephalopathy after steroid treatment. Hyperammonemia due to OTCD was diagnosed and a mutation was found. This allowed us to diagnose two other family members with unexplained encephalopathy who are now asymptomatic on a low-protein diet. OTCD should be considered in any patient with hyperammonemic encephalopathy and immediate treatment should be given to avoid a fatal outcome. We emphasize the need to examine other family members if the diagnosis is confirmed, in order to prevent further life-threatening episodes of encephalopathy or neonatal coma of newborn.

Document Type

Article


Published version

Language

English

Publisher

Hindawi Ltd

Related items

Reproducció del document publicat a: https://doi.org/10.1155/2015/453752

Case Reports in Neurological Medicine, 2015, vol.

https://doi.org/10.1155/2015/453752

Recommended citation

This citation was generated automatically.

Rights

cc by (c) Gascón Bayarri et al., 2015

http://creativecommons.org/licenses/by/3.0/es/